Ann Surg Oncol. RTOG 1010 stage III is normally enrolling sufferers with esophageal HER2-positive adenocarcinoma to be able to create the efficiency of adding trastuzumab to chemoradiation [39]. On the other hand, book HER-2 inhibitors may also be being examined in gastric cancers: lapatinib ditosylate, a dual anti-HER-2 and anti-EGFR tyrosine kinase inhibitor, was firstly … Continue reading Ann Surg Oncol